Latest News for: exosome
Edit
World-First EXO 001 Exosome Platform Enables In Vivo Multi-Target CAR-T for Solid Tumors
PR Newswire 13 Feb 2026
Edit
Exosomes Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | ...
GetNews 13 Feb 2026
Exosomes as an emerging messenger in diagnostics, a rise in exosome-based drug development, exosomes as a promising tool in the field of nanomedicine are some of the important factors that are fueling the Exosomes Market.
Edit
NurExone Biologic Advances Manufacturing and Regulatory Roadmap with Independent Batch Consistency Results for Exosome Production (NurExone Biologic Inc)
Public Technologies 10 Feb 2026
). The text version of this document is not available ... Disclaimer ... (noodl. 129412917) .
Edit
Why Everyone Is Talking About The ‘Exosome Effect’
Sheerluxe 02 Feb 2026
Exosomes are the latest innovation beauty insiders can’t ...
Edit
Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy (Form 6-K) (Alps Group Inc)
Public Technologies 30 Jan 2026
Edit
CMUH-Ever Supreme Team Develops World-First Brain-Targeting Exosome Delivering Curcumin Across the Blood-Brain Barrier for Parkinson's Disease
PR Newswire 28 Jan 2026
Cho Der-Yang, announced a major breakthrough in exosome-based drug delivery, achieved in collaboration with Ever Supreme Bio Technology and Shine-On Biomedical ... The World's First Actively Navigated Brain-Targeting Exosome Drug Delivery Platform.
Edit
Exosome Therapy Market Projected to Reach US$ 309.60 Billion by 2035, Supported by Clinical Translation ...
Nasdaq Globe Newswire 26 Jan 2026
The financial trajectory of the exosome therapy market is decoupling from the broader, slower-growing regenerative medicine sector.
Edit
Creator Chain To Commence DeSci Initiative With Exosome Token
Nasdaq Globe Newswire 14 Jan 2026
Edit
Exosome Research Market Projected to Reach US$ 2,491.42 Million by 2035, Supported by Expanding Therapeutic ...
Nasdaq Globe Newswire 13 Jan 2026
Edit
The Joplin Globe
07 Jan 2026
Pandorum Technologies und Nucelion Therapeutics geben strategische Zusammenarbeit in APAC-Märkten bekannt, um exosom-basierte Therapie zur ...
Edit
St Albans Messenger
06 Jan 2026
Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class ...
... for Shine-On Biomedical's HLA-G targeted exosome program.
Edit
The Galveston Daily News
06 Jan 2026
Pandorum Technologies and Nucelion Therapeutics Announce Strategic Collaboration to Manufacture Exosome-Based Tissue Regenerative Therapy for ...
Edit
Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform
PR Newswire 06 Jan 2026
5, 2026 /PRNewswire/ -- Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical's HLA-G targeted exosome program.
Edit
Pandorum Tech in pact with Bharat Biotech's Nucelion for exosome-based therapeutics
The Times of India 06 Jan 2026
... in advanced biologics manufacturing and a high-quality operational environment that aligns well with our long-term vision of delivering programmable exosome therapies to patients worldwide,” he added.
Edit
Billings Gazette
03 Jan 2026
Phyto Nature E² with next-gen exosomes gives 6 years backx
Regenerative daily exosome and enzyme leave-on resurfaces and accelerates cellular renewal – visibly smoothing, firming, and brightening skin over time ... .
- 1
- 2
- Next page »